Latest Content

How Mammogram Reminders Can Be More Thoughtful Following Breast Cancer

April 28th 2025, 5:00pm

By Felicia Mitchell

I reflect on how a generic mammogram reminder overlooked my experience as a breast cancer survivor and how thoughtful messaging could make a difference.

TAR-200 Achieves High DFS and Bladder Preservation Rates in Bladder Cancer Subgroups

April 28th 2025, 4:00pm

By Ryan Scott

Article

TAR-200 demonstrated a high disease-free survival and bladder preservation rates in BCG-unresponsive, high-risk non-muscle-invasive bladder cancer.

Zongertinib Elicits Responses in HER2-Mutant NSCLC

April 28th 2025, 3:00pm

By Alex Biese

Article

Zongertinib elicited meaningful results in previously treated patients with HER2-mutated, advanced non–small cell lung cancer.

How an Advocate Unites Voices to Guide MPN Research Decisions

April 28th 2025, 1:00pm

By Richard Winneker

Video

Richard Winneker gathers input from patients and researchers to shape MPN research, aiming to fund strategic projects for this population.

Healer, Mentor and Leader

April 27th 2025, 6:00pm

By Susie Maloney, M.S., APRN, AOCN, AOCNS

Article

Reflecting upon my relationship with Jill over the past 25 years, I am in awe of all she has accomplished.

Treatment With HT-KIT Shows Early Preclinical Activity in GIST Models

April 27th 2025, 6:00pm

By Ryan Scott

Article

HT-KIT, a novel targeted therapy for GIST, demonstrated the ability to reduce tumor burden in humanized mouse models and induce tumor cell death.

FDA OKs Investigational New Drug Application for VS-7375 in Solid Tumors

April 26th 2025, 6:00pm

By Spencer Feldman

Article

Verastem will launch a U.S. phase 1/2a trial of oral KRAS G12D inhibitor VS-7375 after FDA IND clearance, with data to be presented at ASCO 2025.

Crafting an Individual Treatment Plan for Patients With Prostate Cancer

April 26th 2025, 2:00pm

By Dr. Curtiland Deville Jr.

Video

Dr. Curtiland Deville Jr. discusses the importance of crafting an individualized treatment plan for patients with prostate cancer.

Commitment to Patients Is Driven by a Lasting Promise

April 25th 2025, 9:00pm

By Christie Griffin-Jones, MBA-HCM, B.S.N., RN, CPHQ, CRRN

Article

Mikela Pettigrew, B.S.N., RN, OCN,, exemplifies extraordinary compassion and dedication. Every day, she fulfills a promise she made as a young caregiver.

Understanding the FDA Imfinzi Combo Approval for Bladder Cancer Care

April 25th 2025, 8:00pm

By Dr. Matthew Galsky

Video

Dr. Matthew Galsky highlights the impact of Imfinzi’s adjuvant approval for patients with muscle-invasive bladder cancer following cystectomy and chemotherapy.

New Options for ER+ Breast Cancer Spotlighted at Patient Event

April 25th 2025, 7:00pm

By Alex Biese

Article

Dr. Brian Czerniecki, of Moffitt Cancer Center, led a CURE Educated Patient® Updates in Metastatic Breast Cancer event, and provided subsequent updates.